Lonza · 2 months ago
OT Engineer
Lonza is a global leader in life sciences, and they are seeking an OT Engineer to support the design, implementation, and maintenance of Operational Technology systems at a pharmaceutical manufacturing site. The role involves ensuring system reliability, cybersecurity, and compliance through robust design and troubleshooting, as well as supporting Computer System Validation activities.
BiotechnologyLife SciencePharmaceutical
Responsibilities
Manage OT systems (PLCs, HMIs, SCADA, BAS/BMS, LIMS/LMS), ensuring compliance with GAMP and 21 CFR Part 11, and maintain architecture, configuration, and asset documentation
Maintain validated backups and perform restoration testing for all OT platforms to ensure disaster recovery readiness and compliance
Lead OT scope in equipment installations and upgrades, supporting FAT/SAT, commissioning, and validation in collaboration with Engineering and IT
Integrate lab instruments with OT infrastructure and troubleshoot automated lab workflows, maintaining documentation and backups
Provide advanced troubleshooting for automation faults and network issues, working with Engineering, QC, Maintenance, and IT to resolve problems
Implement OT cybersecurity controls, manage user access and patching, and support audits with validation and compliance documentation
Author SOPs and validation documents, support cross-functional initiatives, and drive automation optimization and digital transformation efforts
Qualification
Required
Bachelors Degree
5 years of relevant experience
Preferred
Pharma/GMP Experience
Company
Lonza
Lonza Group supplies products and services to pharmaceutical and agrochemical industries.
H1B Sponsorship
Lonza has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2024 (3)
2022 (1)
2021 (3)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$444.8M2023-11-06Post Ipo Debt· $444.8M
2020-12-07IPO
Recent News
NH Business Review
2026-01-17
Company data provided by crunchbase